US 12,279,964 B2
Implants having bone growth promoting agents and methods of using such implants to repair bone structures
Jessee Hunt, Plano, TX (US)
Assigned to 4WEB, LLC, Dallas, TX (US)
Filed by 4WEB, Inc., Frisco, TX (US)
Filed on Jul. 8, 2021, as Appl. No. 17/370,781.
Application 17/370,781 is a continuation in part of application No. 16/657,268, filed on Oct. 18, 2019, granted, now 11,510,787.
Application 16/657,268 is a continuation of application No. 15/721,940, filed on Oct. 1, 2017, abandoned.
Application 15/721,940 is a continuation of application No. 14/743,555, filed on Jun. 18, 2015, granted, now 9,999,516, issued on Jun. 19, 2018.
Application 14/743,555 is a continuation of application No. 12/960,092, filed on Dec. 3, 2010, granted, now 9,421,108, issued on Aug. 23, 2016.
Application 12/960,092 is a continuation of application No. 12/640,825, filed on Dec. 17, 2009, granted, now 8,430,930, issued on Apr. 30, 2013.
Claims priority of provisional application 63/049,122, filed on Jul. 8, 2020.
Claims priority of provisional application 61/138,707, filed on Dec. 18, 2008.
Prior Publication US 2021/0330473 A1, Oct. 28, 2021
Int. Cl. A61F 2/44 (2006.01); A61B 17/16 (2006.01); A61B 17/56 (2006.01); A61B 17/58 (2006.01); A61B 17/68 (2006.01); A61F 2/28 (2006.01); A61F 2/30 (2006.01); A61F 2/32 (2006.01); A61F 2/38 (2006.01); A61F 2/40 (2006.01); A61F 2/42 (2006.01); A61F 2/46 (2006.01); A61B 17/02 (2006.01); A61F 2/36 (2006.01); B33Y 70/00 (2020.01); B33Y 80/00 (2015.01)
CPC A61F 2/4455 (2013.01) [A61B 17/1604 (2013.01); A61B 17/56 (2013.01); A61B 17/58 (2013.01); A61B 17/68 (2013.01); A61F 2/28 (2013.01); A61F 2/2803 (2013.01); A61F 2/2846 (2013.01); A61F 2/30767 (2013.01); A61F 2/30771 (2013.01); A61F 2/30907 (2013.01); A61F 2/32 (2013.01); A61F 2/38 (2013.01); A61F 2/40 (2013.01); A61F 2/4202 (2013.01); A61F 2/4225 (2013.01); A61F 2/447 (2013.01); A61F 2/4611 (2013.01); A61B 17/025 (2013.01); A61F 2002/2817 (2013.01); A61F 2002/2835 (2013.01); A61F 2002/30153 (2013.01); A61F 2002/30156 (2013.01); A61F 2002/30158 (2013.01); A61F 2002/30179 (2013.01); A61F 2002/30273 (2013.01); A61F 2002/30275 (2013.01); A61F 2002/3028 (2013.01); A61F 2002/30281 (2013.01); A61F 2002/30593 (2013.01); A61F 2002/30599 (2013.01); A61F 2002/30841 (2013.01); A61F 2002/30899 (2013.01); A61F 2002/30909 (2013.01); A61F 2002/30914 (2013.01); A61F 2002/3092 (2013.01); A61F 2/3094 (2013.01); A61F 2002/30943 (2013.01); A61F 2002/30952 (2013.01); A61F 2002/30953 (2013.01); A61F 2002/30957 (2013.01); A61F 2002/30962 (2013.01); A61F 2002/30968 (2013.01); A61F 2002/3097 (2013.01); A61F 2/36 (2013.01); A61F 2002/4628 (2013.01); A61F 2210/0076 (2013.01); A61F 2230/0063 (2013.01); A61F 2310/00011 (2013.01); A61F 2310/00017 (2013.01); A61F 2310/00023 (2013.01); A61F 2310/00029 (2013.01); A61F 2310/00047 (2013.01); A61F 2310/00179 (2013.01); A61F 2310/00598 (2013.01); A61F 2310/00796 (2013.01); A61F 2310/00958 (2013.01); A61F 2310/0097 (2013.01); A61F 2310/00976 (2013.01); B33Y 70/00 (2014.12); B33Y 80/00 (2014.12)] 16 Claims
OG exemplary drawing
 
1. An implant for interfacing with a bone structure, comprising:
a web structure comprising a plurality of struts joined at nodes, wherein the web structure is configured to interface with human bone tissue;
a plurality of biocompatible fibers coated on one or more of the plurality of struts; and
a plurality of biodegradable particles contained within the biocompatible fibers, the biodegradable particles encapsulating one or more bone growth promoting agents, wherein the biodegradable particles dissolve in the presence of biological fluids in order to release the encapsulated bone growth promoting agents, and wherein the biodegradable particles include particles of varying sizes where different size particles release the encapsulated bone growth promoting at different times in the of the biological fluid.